model-based therapeutic drug monitoring in...
TRANSCRIPT
![Page 1: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/1.jpg)
Model-basedTherapeutic Drug Monitoring
in Oncology
Ron Keizer PharmD PhD
Chief Scientific Officer, InsightRXSan Francisco, CA
![Page 2: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/2.jpg)
Disclosure
InsightRX isaprecisiondosingsoftwarecompany,developingsoftwareforhealthcareproviders
andpharmaindustry.
![Page 3: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/3.jpg)
“Model-based”Why do we need it for TDM?
![Page 4: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/4.jpg)
History: Model-based TDM
1972
1972
1969
![Page 5: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/5.jpg)
Product Active PI / founder Since LocationInsightRX yes InsightRX 2015 USDoseMe yes Green, McLeay 2012 AustraliaUSC*Pack no Roger Jelliffe 1970s LA, USBestDose yes Michael Neely 200x LA, USNextDose ? Sam Holford 2012 AustraliaBaysient no Diane Mould 2015 USMW/Pharm yes Hans Proost 1990s The Netherlands / Czech Rep.TCIworks no Stephen Duffull 2010s New ZealandTDMS2000 no Healthware Inc 1980s San Diego, USPrecise PK yes Healthware Inc 2010s San Diego, USTDMx yes Sebastian Wicha 2015 GermanyAutoKinetics yes Paul Elbers 2015 The NetherlandsEzeCHiel no Thierry Buclin 2013 SwitzerlandTucuxi yes Thierry Buclin 2016 SwitzerlandOptimum Dosing Strategies yes Andras Farkas 2013 USMyPKFit yes Baxter 2014 US
Model-based TDM software (a selection)
![Page 6: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/6.jpg)
TDM without modeling & simulation?
Example1: e.g.vancomycin/voriconazole
- Waitfor“steadystate”- GetCmin atrighttime- Comparetoreference/effectiverange
Drawbacks:- Oftenincorrectlydrawn
(e.g.87%ofvancomycintroughlevelsatmajorUSacademiccenter*)
- Sensitivetodataerrors
Advantages:- Intuitive/simple
Example1b:e.g.vancomycin/imatinib**
- Waitfor“steadystate”- Getsampleatanytimepoint- ExtrapolatetoCmin (orCmax /AUC)
Drawbacks:- Extrapolationusingpopulationvalue- imprecise/biased- Sensitivetodataerrors
Advantages:- Intuitive
* personal communication Deborah French et al. 2013. (“incorrect”: more than 30 minutes early, or not at steady state)** Wang Y et al. Ther Drug Monit. 2009
![Page 7: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/7.jpg)
TDM without modeling & simulation?
Example2:e.g.busulfan
• Collectrichdata(4-8samples)eachday• CalculateAUC(usingNCA/trapezoidalrule)
Advantages• Intuitive
Drawbacks• Onlyprecisewithmanysamples• Requirestime&efforttocalculate• Sensitivetodataerrors
![Page 8: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/8.jpg)
Model-based dosing: example
![Page 9: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/9.jpg)
Model-based dosing: example
![Page 10: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/10.jpg)
Model-based dosing: example
![Page 11: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/11.jpg)
Model-based dosing: example
![Page 12: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/12.jpg)
Model-based dosing: example
![Page 13: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/13.jpg)
Model-based dosing: example
![Page 14: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/14.jpg)
Model-based dosing: example
![Page 15: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/15.jpg)
Model-based dosing: example
![Page 16: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/16.jpg)
Model-based dosing: example
![Page 17: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/17.jpg)
Model-based dosing: example
![Page 18: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/18.jpg)
Model-based dosing: example
Higherprecision• Abilitytoincorporateknownpredictors(weight,eGFR,genotypes,etc)• Protectsagainstdataerrors/processnoise• Usein“apriori”and“afterTDM”setting
Lesssamples• Relaxsamplingtimewindows• Optimizesamplingwindows(throughOptimalDesign,MCsimulation)
![Page 19: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/19.jpg)
Model-based dosing: example
Moreinformative• Comparewithpopulationà detectoutlier
![Page 20: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/20.jpg)
Model-based dosing: example
Moreinformative• Comparewithpopulationà detectoutlier• Providesuncertaintyestimates
![Page 21: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/21.jpg)
Model-based dosing: example
Moreinformative• Comparewithpopulationà detectoutlier• Providesuncertaintyestimates• Simulation:“what-if”scenarios• LinktoPDmeasures/outcome
![Page 22: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/22.jpg)
TDM in OncologyExamples, Highlights, etc.
![Page 23: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/23.jpg)
Busulfan: Improving precision
Bartelink etal.Lancet Haematol 2016
![Page 24: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/24.jpg)
Busulfan: Improving precision
Bartelink etal.Lancet Haematol 2016
![Page 25: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/25.jpg)
Busulfan: Improving precision
1.Savic RMetal.Biol BloodMarrowTransplant20132.Long-BoyleJetal.Therap Drug Monit 20153.Bartelink etal.LancetHaematol 20163.Keizeretal.Unpublished
<2014:Conventional(label-dose) used.TDMusingNCA(7samples/day)
2014:UCSF developspopPK modelbusulfan [1,2]
2015:UCSFstartsusingin-houseExcel app forinitialdose
2016: UCSFswitchestomodel-basedTDM
2016:popPK modelreoptimized[4]
![Page 26: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/26.jpg)
Busulfan: Improving precision
Shukla Petal.(2017,unpublished)
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●●
●
●
●●
●
●
●●
●●
● ●
●
●
●
●
●● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●●
●
●
●●
●
●
●
0.0
0.5
1.0
1.5
Conventional + NCA Model−based + NCA Model−based + Bayesian
Rel
ativ
e ta
rget
atta
inm
ent
InitialdoseAUC
![Page 27: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/27.jpg)
Busulfan: Improving precision
ShuklaPetal.(2017,unpublished)
●
●
●
● ●
●
●
●●●
●
●
●●
●●
●
●●
●
●
●●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●●
●
●●
●
●
●●
●
●
●
●●●
●●
●
●
●●
●●
●●
●
●
●
●
●●● ●●
● ●●●
0.0
0.5
1.0
1.5
Conventional + NCA Model−based + NCA Model−based + Bayesian
Rel
ativ
e ta
rget
atta
inm
ent
CumulativeAUC
![Page 28: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/28.jpg)
TDM in Oncology
Randomizedtrials:
• MTX:Evansetal.NEJM1998
• 5-FU:Fety etal. Clin CancerRes1998• 5-FU:Gamelin etal.JCO2012
• Paclitaxel:Joerger etal.AnnOncol 2016
![Page 29: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/29.jpg)
Why TDM not used more widely for cytotoxic drugs?
Thoughts:
• Drugcombinationsàmorecomplex
• Investigator-initiatedtrials
• Decreasedtoxicityratherthanimprovedefficacy?
• Moreinvolved(e.g.vspharmacogenetics)
• …?
![Page 30: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/30.jpg)
BSA paradigm
“Theexposureforfluorouracilvaries30- to100-foldandfordocetaxeluptoseven-fold.[…]Itwouldbemoreappropriatetotitrateanindividualpatient’sdosetoanMTEbymeansoftherapeuticdrugmonitoring.”
Beumer JetalJCO2012
![Page 31: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/31.jpg)
BSA paradigm
Beumer JetalJCO2012
“Letushopethat,in another50years,we arenotstillrecommendingBSA-baseddosingandthatwewillhavemovedtodosingapatientwiththerightdrugatwhateverdoserequiredtoachievetherightexposure.”
![Page 32: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/32.jpg)
TDM in Targeted Oncology
![Page 33: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/33.jpg)
Imatinib: TDM or not?
Demetrietal.JCO2009
![Page 34: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/34.jpg)
Imatinib: TDM or not?
Picardetal.JCO2009
![Page 35: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/35.jpg)
Imatinib: TDM or not?
Gotta Vetal.CancerChemother Pharmacol 2014
![Page 36: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/36.jpg)
Imatinib: TDM or not?
Gotta V etal.Leuk Res2014
![Page 37: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/37.jpg)
Imatinib: TDM or not?
Gotta V etal.Leuk Res2014
![Page 38: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/38.jpg)
Imatinib: TDM or not?
![Page 39: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/39.jpg)
Pharmacodynamicmodel-based dosing
![Page 40: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/40.jpg)
Neutrophil-guided dosing
Wallin JE etal.BasicClin Pharmacol Tox 2010Wallin JEetal.Comput MethodsProgramsBiomed2009
![Page 41: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/41.jpg)
Neutrophil-guided dosing
Wallin JE etal.BasicClin Pharmacol Tox 2010Wallin JEetal.Comput MethodsProgramsBiomed2009
![Page 42: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/42.jpg)
Neutrophil-guided dosing
![Page 43: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/43.jpg)
Neutrophil-guided dosing
Netterberg I. CancerChemotherap Pharmacol 2017
![Page 44: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/44.jpg)
Vision: 2025
Integratedwith EMR
Linksexposure~outcomeestablished
Reimbursed bypayer
Includedindruglabel
“Companion”apps
![Page 45: Model-based Therapeutic Drug Monitoring in Oncologyregist2.virology-education.com/presentations/2ndonco/s2... · 2017. 9. 19. · TDM without modeling & simulation? Example 1:e.g](https://reader034.vdocuments.net/reader034/viewer/2022052010/60201aafdedbe66feb3812d3/html5/thumbnails/45.jpg)
Thank you
Slides:science.insight-rx.com
Publications:Referencesinindividualslides
Recommendedfurtherreading:WilliamClarke”TDMforcanceragents”: https://www.youtube.com/watch?v=OhDnVr3n4H8Saladax website: http://www.saladax.com/publications-2